Erytech Pharma SA Price Prediction
| ERYPDelisted Stock | USD 0.78 0.04 4.88% |
Oversold Vs Overbought
46
Oversold | Overbought |
Using Erytech Pharma hype-based prediction, you can estimate the value of Erytech Pharma SA from the perspective of Erytech Pharma response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Erytech Pharma to buy its stock at a price that has no basis in reality. In that case, they are not buying Erytech because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Erytech Pharma after-hype prediction price | USD 0.78 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Erytech |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Erytech Pharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Erytech Pharma After-Hype Price Prediction Density Analysis
As far as predicting the price of Erytech Pharma at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Erytech Pharma or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Erytech Pharma, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Erytech Pharma Estimiated After-Hype Price Volatility
In the context of predicting Erytech Pharma's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Erytech Pharma's historical news coverage. Erytech Pharma's after-hype downside and upside margins for the prediction period are 0.78 and 0.78, respectively. We have considered Erytech Pharma's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Erytech Pharma is very steady at this time. Analysis and calculation of next after-hype price of Erytech Pharma SA is based on 3 months time horizon.
Erytech Pharma Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Erytech Pharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Erytech Pharma backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Erytech Pharma, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 3 Events / Month | 11 Events / Month | In about 3 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.78 | 0.78 | 0.00 |
|
Erytech Pharma Hype Timeline
Erytech Pharma SA is currently traded for 0.78. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Erytech is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is currently at 0.0%. %. The volatility of related hype on Erytech Pharma is about 0.0%, with the expected price after the next announcement by competition of 0.78. The company has price-to-book (P/B) ratio of 0.65. Some equities with similar Price to Book (P/B) outperform the market in the long run. Erytech Pharma SA recorded a loss per share of 0.01. The entity had not issued any dividends in recent years. Given the investment horizon of 90 days the next anticipated press release will be in about 3 days. Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.Erytech Pharma Related Hype Analysis
Having access to credible news sources related to Erytech Pharma's direct competition is more important than ever and may enhance your ability to predict Erytech Pharma's future price movements. Getting to know how Erytech Pharma's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Erytech Pharma may potentially react to the hype associated with one of its peers.
Erytech Pharma Additional Predictive Modules
Most predictive techniques to examine Erytech price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Erytech using various technical indicators. When you analyze Erytech charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Erytech Pharma Predictive Indicators
The successful prediction of Erytech Pharma stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Erytech Pharma SA, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Erytech Pharma based on analysis of Erytech Pharma hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Erytech Pharma's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Erytech Pharma's related companies.
Story Coverage note for Erytech Pharma
The number of cover stories for Erytech Pharma depends on current market conditions and Erytech Pharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Erytech Pharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Erytech Pharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Erytech Pharma Short Properties
Erytech Pharma's future price predictability will typically decrease when Erytech Pharma's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Erytech Pharma SA often depends not only on the future outlook of the potential Erytech Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Erytech Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 31 M | |
| Cash And Short Term Investments | 38.8 M |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Consideration for investing in Erytech Stock
If you are still planning to invest in Erytech Pharma SA check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Erytech Pharma's history and understand the potential risks before investing.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |